Navigation Links
Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
Date:5/4/2009

ore efficient and frequent interactions. These changes build on Amylin's scientific strength, and leverage Lilly's expertise and reach with primary care prescribers, so that we are well positioned to address the information needs of the complex diabetes market," said Daniel M. Bradbury, president and chief executive officer at Amylin Pharmaceuticals. "Today's actions are in line with our stated goal of achieving positive operating cash flow by the end of 2010, while continuing to position the company to increase sales of BYETTA and SYMLIN and bring exenatide once weekly to market as quickly as possible."

Mr. Bradbury continued, "We appreciate the significant contributions of field sales employees who will be affected by today's announcement and are grateful for their efforts and dedication to Amylin's mission."

The sales force changes will result in an annualized benefit of approximately $45 million in GAAP operating results in 2010, and a partial year benefit of approximately $20 million in 2009, which includes reductions in field sales staff and expenses, partially offset by additional cost-sharing for Lilly's primary care sales efforts. As a result of these expense reductions, which are primarily cash expenses, the Company estimates that total GAAP operating expenses for 2009 will now be at the lower end of the previously stated guidance range of $600 million to $625 million, and GAAP operating loss will also be at the lower end of the previously stated guidance range of $175 million to $200 million. This guidance for GAAP operating loss excludes a restructuring charge, estimated to be approximately $13 to $15 million, which the Company will record in the second quarter, consisting of primarily severance and other employee-related costs.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commerciali
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... MARLBOROUGH, Mass. , May 27, 2015 /PRNewswire/ ... a biotechnology company focused on discovering and developing ... and ophthalmology, today announced that it has commenced a ... warrants to purchase shares of its common stock ... its common stock. The shares of common stock, ...
(Date:5/27/2015)... Muncie, IN (PRWEB) May 27, 2015 The ... public to join in celebrating National Model Aviation Day. The ... Aviation Day was created to celebrate the model aviation hobby ... AMA encourages all of its approximately 2,350 chartered clubs to ... hosting an event in their communities. There will also be ...
(Date:5/27/2015)... AVIV, Israel , May 27, 2015  Tikcro ... first quarter ended March 31, 2015. ... the quarter, we continued pre-clinical work to generate functional ... in an early stage, we are encouraged by the ... this field as new antibodies which modulate immune checkpoints ...
(Date:5/27/2015)... SOUTH SAN FRANCISCO, Calif. , May 27, ... therapeutics for the treatment of cancer, today announced ... chief financial officer and Cynthia Ladd ... to joining CytomX, Goeltz was chief financial officer ... previously served as an independent consultant and legal ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Academy of Model Aeronautics Foundation to host National Model Aviation Day Motorcycle Rally and Family Fest in Muncie, IN 2Academy of Model Aeronautics Foundation to host National Model Aviation Day Motorcycle Rally and Family Fest in Muncie, IN 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3
... plant-derived insulin program, scheduled to enter the ... SBS, CALGARY, July 29 /PRNewswire-FirstCall/ - SemBioSys ... of therapeutic,proteins for metabolic and cardiovascular diseases, today ... (IND) application for,safflower-produced recombinant human insulin to the ...
... American College of Chest Physicians (ACCP) Guidelines Will Increase ... Use of Trellis(R) Peripheral Infusion ... College of Chest,Physicians (ACCP) has published new evidence-based clinical ... use of pharmacomechanical,thrombolysis for acute iliofemoral deep vein thrombosis ...
... Washington, DC State and local officials have taken ... nanomaterials, a major step for a cutting-edge technology that ... , On July 28, the Cambridge (Mass.) Public ... take several steps to gain a better understanding of ...
Cached Biology Technology:SemBioSys submits IND for safflower-produced insulin to U.S. FDA 2SemBioSys submits IND for safflower-produced insulin to U.S. FDA 3Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT 2Local officials move toward monitoring nanotechnologies 2Local officials move toward monitoring nanotechnologies 3
(Date:5/28/2015)... , May 28, 2015 Industry analyst ... a new report titled "Markets for Self-Healing Materials: ... inorganic capsule and vascular systems, biomaterials, relevant shape ... to around $2.7 billion by 2020. ... extensive coverage of smart materials. Other recent n-tech reports ...
(Date:5/27/2015)... 27, 2015   Codonics (codonics.com), ... and image documentation solutions and Omnicell ... automation solutions, is pleased to announce their ... Safe Label System® (SLS), an award-winning FDA ... the Omnicell Anesthesia Workstation, helps prevent medication ...
(Date:5/26/2015)... Research and Markets ( ... "Saudi Arabia Biometric Systems Market Forecast and ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems market in ... to grow at over 22% CAGR through 2020 ... the surging demand for better biometric technologies in ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2
... A new study investigating the respiratory system of insects ... for decades: why insects routinely stop breathing for minutes ... UC Irvine and Humboldt University propose that insects such ... beetles and bugs close off their respiratory systems periodically ...
... a stunning example of evolution at work, scientists have now ... changes in the skeletal armor of fish living in the ... 2005, issue of journal Science, bring new data to long-standing ... motivation is to try to understand how new animal types ...
... accustomed to nesting on islands free of predators began ... in the Aleutian archipelago in the 18th century. The ... study published this week in the journal Science now ... through entire island ecosystems, transforming the vegetation from lush ...
Cached Biology News:Why do insects stop 'breathing'? To avoid damage from too much oxygen, say researchers 2Why do insects stop 'breathing'? To avoid damage from too much oxygen, say researchers 3Octopuses occasionally stroll around on two arms, UC Berkeley biologists report 2Octopuses occasionally stroll around on two arms, UC Berkeley biologists report 3Octopuses occasionally stroll around on two arms, UC Berkeley biologists report 4Octopuses occasionally stroll around on two arms, UC Berkeley biologists report 5Introduced foxes transformed vegetation on Aleutian Islands from lush grasslands to tundra 2Introduced foxes transformed vegetation on Aleutian Islands from lush grasslands to tundra 3Introduced foxes transformed vegetation on Aleutian Islands from lush grasslands to tundra 4
... Camera hood with 5.6" TFT color screen, without ... system use digital camera with 8.0 mega pixel ... requirements and small budget. View image from large ... specific feature. It is suitable to capture image ...
... DNA detection has been improved. With Gene Coloring ... can be detected > 20 ng. The excised ... organic solvent extraction or with other commercially available ... DNA excised from agarose gel can be used ...
...
Mouse monoclonal antibody raised against a full length recombinant CSNK2A2. NCBI Entrez Gene ID = CSNK2A2...
Biology Products: